ATE240317T1 - Indolderivate als pkc-inhibitoren - Google Patents
Indolderivate als pkc-inhibitorenInfo
- Publication number
- ATE240317T1 ATE240317T1 AT98965324T AT98965324T ATE240317T1 AT E240317 T1 ATE240317 T1 AT E240317T1 AT 98965324 T AT98965324 T AT 98965324T AT 98965324 T AT98965324 T AT 98965324T AT E240317 T1 ATE240317 T1 AT E240317T1
- Authority
- AT
- Austria
- Prior art keywords
- indole derivatives
- pkc inhibitors
- pkc
- inhibitors
- indole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704874A SE9704874D0 (sv) | 1997-12-23 | 1997-12-23 | New pharmaceutically active compounds |
SE9802539A SE9802539D0 (sv) | 1998-07-13 | 1998-07-13 | New pharmaceutically active compounds |
PCT/SE1998/002300 WO1999032483A1 (en) | 1997-12-23 | 1998-12-14 | New pharmaceutically active compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE240317T1 true ATE240317T1 (de) | 2003-05-15 |
Family
ID=26663171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98965324T ATE240317T1 (de) | 1997-12-23 | 1998-12-14 | Indolderivate als pkc-inhibitoren |
Country Status (8)
Country | Link |
---|---|
US (1) | US6337342B1 (de) |
EP (1) | EP1042317B1 (de) |
JP (1) | JP2001526287A (de) |
AR (1) | AR017200A1 (de) |
AT (1) | ATE240317T1 (de) |
AU (1) | AU2080199A (de) |
DE (1) | DE69814685T2 (de) |
WO (1) | WO1999032483A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9800835D0 (sv) | 1998-03-13 | 1998-03-13 | Astra Ab | New Compounds |
SE9802538D0 (sv) * | 1998-07-13 | 1998-07-13 | Astra Ab | New pharmaceutically active compounds |
US6492406B1 (en) | 1999-05-21 | 2002-12-10 | Astrazeneca Ab | Pharmaceutically active compounds |
SE9902387D0 (sv) * | 1999-06-22 | 1999-06-22 | Astra Ab | New pharmaceutically active compounds |
US6346625B1 (en) | 1999-06-23 | 2002-02-12 | Astrazeneca Ab | Protein kinase inhibitors |
DE19948417A1 (de) * | 1999-10-07 | 2001-04-19 | Morphochem Ag | Imidazol-Derivate und ihre Verwendung als Arzneimittel |
WO2002038532A1 (fr) * | 2000-11-09 | 2002-05-16 | Mitsui Chemicals, Inc. | Derive d'amine optiquement actif et methode de synthese |
TWI339206B (en) * | 2003-09-04 | 2011-03-21 | Vertex Pharma | Compositions useful as inhibitors of protein kinases |
CA2618724A1 (en) * | 2005-08-18 | 2007-02-22 | Synta Pharmaceuticals Corp. | Imidazole compounds that modulate hsp90 activity |
AU2007267843B2 (en) | 2006-05-25 | 2011-10-13 | Synta Pharmaceuticals Corp. | Method for treating proliferative disorders associated with protooncogene products |
US9205086B2 (en) | 2010-04-19 | 2015-12-08 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor |
AU2012332421A1 (en) | 2011-11-02 | 2014-06-05 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of Hsp90 inhibitors with topoisomerase I inhibitors |
CA2853806C (en) | 2011-11-02 | 2020-07-14 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitors with platinum-containing agents |
WO2013074594A1 (en) | 2011-11-14 | 2013-05-23 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitors with braf inhibitors |
RU2720490C1 (ru) * | 2019-11-05 | 2020-04-30 | Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) | 3-(2-оксоимидазолидинил-5)индолы и способ их получения |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE28973E (en) | 1965-10-23 | 1976-09-21 | A. H. Robins Company, Incorporated | 3-(Omega-substituted alkyl)-indoles |
US3821387A (en) | 1965-10-23 | 1974-06-28 | Robins Co Inc A H | The treatment of parkinsonism with 3-(omega-substituted alkyl)-indoles |
US3821389A (en) | 1969-10-31 | 1974-06-28 | Sherwin Williams Co | Microbiocidal use of 1,2-benzisothiazolin-3-ones |
SU389096A1 (de) | 1971-07-01 | 1973-07-05 | ||
FR2182915A1 (en) | 1972-03-30 | 1973-12-14 | Nelson Res & Dev | Substd indoles, benzimidazoles - as anti-immune agents , antitumour agents, serotonin inhibitors, hypnotics |
US4031221A (en) | 1974-06-17 | 1977-06-21 | American Hoechst Corporation | Method of treating pain and hypertension |
GB1500176A (en) | 1975-06-03 | 1978-02-08 | Wyeth John & Brother Ltd | Reduction process for the preparation of 1-unsubstituted 3-(2-hydroxyethyl)-indole derivatives |
DE3132882A1 (de) | 1981-08-20 | 1983-03-03 | Cassella Ag, 6000 Frankfurt | Neue piperazinone, ihre herstellung und verwendung |
DE3141063A1 (de) | 1981-10-13 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
US4532250A (en) | 1983-11-23 | 1985-07-30 | American Hospital Supply Corporation | 5-Heteroarylimidazol-2-ones having cardiotonic activity |
US4912125A (en) | 1985-09-03 | 1990-03-27 | Ciba-Geigy Corporation | 2,3-dihydro-2-(4,5-dihydroimidazol-2-yl)-indoles for reducing intraocular pressure |
NZ227850A (en) | 1988-02-10 | 1991-11-26 | Hoffmann La Roche | Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders |
US5380746A (en) | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
GB9413975D0 (en) | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
WO1991018897A1 (en) | 1990-06-07 | 1991-12-12 | The Wellcome Foundation Limited | Therapeutic heterocyclic compounds |
US5077293A (en) | 1990-06-29 | 1991-12-31 | Bristol-Myers Squibb Co. | 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines |
US5192770A (en) | 1990-12-07 | 1993-03-09 | Syntex (U.S.A.) Inc. | Serotonergic alpha-oxoacetamides |
GB9123396D0 (en) | 1991-11-04 | 1991-12-18 | Hoffmann La Roche | A process for the manufacture of substituted maleimides |
EP0630241A1 (de) | 1992-03-20 | 1994-12-28 | The Wellcome Foundation Limited | Indolderivate mit antiviraler wirkung |
GB9222262D0 (en) | 1992-10-23 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
EP1449529B1 (de) | 1993-12-23 | 2010-01-27 | Eli Lilly And Company | Proteinkinase C Inhibitoren |
US5545636A (en) | 1993-12-23 | 1996-08-13 | Eli Lilly And Company | Protein kinase C inhibitors |
CA2144940A1 (en) | 1994-03-18 | 1995-09-19 | Chikara Murakata | Therapeutic agent for thrombocytopenia and indolocarbazole derivatives |
SI0776895T1 (en) | 1995-11-20 | 1999-04-30 | Eli Lilly And Company | Protein kinase C inhibitor |
EA001392B1 (ru) | 1996-08-23 | 2001-02-26 | Эли Лилли Энд Компани | Синтез бисиндолилмалеимидов |
SE9603283D0 (sv) | 1996-09-10 | 1996-09-10 | Astra Ab | New compounds |
TW472045B (en) | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
US5854285A (en) | 1997-04-03 | 1998-12-29 | Natpro, Inc. | Protein kinase inhibitor |
CA2325588A1 (en) | 1998-03-25 | 1999-09-30 | Bristol-Myers Squibb Company | Imidazolone anorectic agents: i. acyclic derivatives |
-
1998
- 1998-12-09 AR ARP980106242A patent/AR017200A1/es unknown
- 1998-12-14 JP JP2000525420A patent/JP2001526287A/ja active Pending
- 1998-12-14 DE DE69814685T patent/DE69814685T2/de not_active Expired - Fee Related
- 1998-12-14 EP EP98965324A patent/EP1042317B1/de not_active Expired - Lifetime
- 1998-12-14 WO PCT/SE1998/002300 patent/WO1999032483A1/en active IP Right Grant
- 1998-12-14 US US09/230,710 patent/US6337342B1/en not_active Expired - Fee Related
- 1998-12-14 AT AT98965324T patent/ATE240317T1/de not_active IP Right Cessation
- 1998-12-14 AU AU20801/99A patent/AU2080199A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1042317B1 (de) | 2003-05-14 |
JP2001526287A (ja) | 2001-12-18 |
AR017200A1 (es) | 2001-08-22 |
EP1042317A1 (de) | 2000-10-11 |
DE69814685D1 (de) | 2003-06-18 |
US6337342B1 (en) | 2002-01-08 |
WO1999032483A1 (en) | 1999-07-01 |
DE69814685T2 (de) | 2004-02-19 |
AU2080199A (en) | 1999-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE251612T1 (de) | 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren | |
DK1001934T3 (da) | Indolforbindelser som COX-2-inhibitorer | |
ATE293599T1 (de) | Indolderivate als faktor xa inhibitoren | |
DE69716615D1 (de) | Heterozyklische metalloproteaseinhibitoren | |
DK0958287T3 (da) | Sulfamidmetalloprotease-inhibitorer | |
ATE278695T1 (de) | Piperidinderivate | |
ATE240317T1 (de) | Indolderivate als pkc-inhibitoren | |
ATE255098T1 (de) | Substituierte chromanderivate | |
ATE308519T1 (de) | 2,3-substituierte indolverbindungen als cox-2 inhibitoren | |
DE69706823T2 (de) | Bicyclische 4-aralkylaminopyrimidin-derivate als tyrosinkinase-inhibitoren | |
NO20001215D0 (no) | Substituerte 2-pyrrolidinonaktivatorer for PKC | |
ATE255099T1 (de) | Substituierte chromanderivate | |
DE69837922D1 (de) | Il-5 hemmende 6-azauracilderivate | |
ATE299876T1 (de) | Indolderivate | |
NO20020306L (no) | Indolderivater | |
IS6434A (is) | Nýjar indól afleiður | |
DE69717811T2 (de) | Substituierte phenethyl-derivate als matrx-metalloprotease-inhibitoren | |
DE69908330D1 (de) | 5-heteroaryl-substituierte indole | |
DK0725061T3 (da) | Substituerede indolderivater | |
ATE238287T1 (de) | 6-azauracilderivate als il-5 inhibitoren | |
NO20001778L (no) | Substituerte piperidinderivater | |
DE59605373D1 (de) | Substituierte Indol-Derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |